OpenVSafe by OpenVAERS
Search V-safe

A9C-18367-89719

3 vaccinations 1 coded response 14 check-ins 0 free-text entries 1 call case
Sex
Male
Age at first dose
12-15
ZIP prefix
024 / MA
Registered
2022-01-28
Relationship
Child or adolescent in my care
Guardian
YVQ-17152-44169
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-05-13
    Dose 1 — Pfizer-BioNTech
  2. 2021-06-03
    Dose 2 — Pfizer-BioNTech
  3. 2022-01-28
    Registered in v-safe
  4. 2022-01-28
    Dose 3 — Pfizer-BioNTech
  5. 2022-01-28
    Health check-in — day 0, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  6. 2022-01-29
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2022-01-30
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  8. 2022-01-31
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  9. 2022-02-02
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  10. 2022-02-05
    Health check-in — day 7, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  11. 2022-02-11
    Health check-in — day 14, dose 3, dependent
    Feeling: Good
    Adult check-in
  12. 2022-02-18
    Health check-in — day 21, dose 3, dependent
    Feeling: Good
    Adult check-in
  13. 2022-02-25
    Health check-in — day 28, dose 3, dependent
    Feeling: Good
    Adult check-in
  14. 2022-03-04
    Health check-in — day 35, dose 3, dependent
    Feeling: Good
    Adult check-in
  15. 2022-03-11
    Health check-in — day 42, dose 3, dependent
    Feeling: Good
    Adult check-in
  16. 2022-04-29
  17. 2022-07-31
  18. 2023-01-28
    Survey response — 12 months, dose 3, dependent
    MedDRA: Fatigue — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11
  19. 2023-01-28
    Report sent to call center — 12 months, dose 3, dependent
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  20. 2023-01-30
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-05-13Pfizer-BioNTech No
22021-06-03Pfizer-BioNTech No
32022-01-28Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2023-01-28 Successful
2023-01-30
Participant prefers to complete VAERS report online

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDFatigue · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release